Allergic rhinitis. Allergic rhinitis, unspecified
Conditions
Interventions
Intervention 1: Control group: patients with allergic rhinitis treated with placebo tablets once a day (similar to glucosamine tablets but containing sugar) manufactured by Abidi Pharmaceuticals for 1
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with allergic rhinitis Diagnosis of allergic rhinitis by an otolaryngologist Allergic rhinitis more than 12 weeks ?? ????? 18 ??? ??? ???? ?? ????? ??? ????? (???? ???????? ? ????? ??? ?????)
Exclusion criteria
Exclusion criteria: Hypersensitivity to glucosamine or similar compounds The presence of hypersensitivity reactions in the patient Existence of systemic diseases (such as diabetes, hypertension, dyslipidemia, etc.) Patients who have tumors in the nose and sinuses Patients who have had any surgery on the nose and sinuses.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum IgE level. Timepoint: before and after the 15 days course of treatment. Method of measurement: blood sample.;Total nasal symptom scores. Timepoint: before and after the 15 days course of treatment. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Rezaeian
Esfahan University of Medical Sciences
Outcome results
None listed